Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.26M Buy
+823,461
New +$1.25M ﹤0.01% 2824
2025
Q2
Sell
-756,926
Closed -$535K 3367
2025
Q1
$535K Hold
756,926
﹤0.01% 2887
2024
Q4
$609K Hold
756,926
﹤0.01% 2913
2024
Q3
$751K Hold
756,926
﹤0.01% 2872
2024
Q2
$1.17M Buy
+756,926
New +$1.18M ﹤0.01% 2654
2023
Q2
Sell
-672,249
Closed -$573K 3263
2023
Q1
$573K Sell
672,249
-483,391
-42% -$527K ﹤0.01% 2774
2022
Q4
$1.5M Buy
1,155,640
+459,386
+66% +$716K ﹤0.01% 2503
2022
Q3
$1.24M Sell
696,254
-14,825
-2% -$36.9K ﹤0.01% 2650
2022
Q2
$1.61M Sell
711,079
-38,040
-5% -$91K ﹤0.01% 2546
2022
Q1
$2.79M Sell
749,119
-231,969
-24% -$815K ﹤0.01% 2360
2021
Q4
$4.46M Buy
981,088
+172,984
+21% +$1.31M ﹤0.01% 2188
2021
Q3
$5.8M Buy
808,104
+50,073
+7% +$368K ﹤0.01% 2123
2021
Q2
$6.09M Buy
+758,031
New +$6.4M ﹤0.01% 2146

Other funds holding OCGN

Nuveen's OCGN Position: Q2 2026 in Review

Nuveen opened a new position in Ocugen (OCGN) in Q2 2026: 823,461 shares worth $1.26M. The stake represents ﹤0.01% of the portfolio and ranks #2824 among its holdings. This is a return to the name: Nuveen previously reported a position in OCGN as recently as Q1 2025.

Nuveen first reported a position in OCGN in Q2 2021 and has held it in 13 quarters since. The position peaked at $6.09M in Q2 2021. 147 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.

  • Nuveen held 823,461 shares of Ocugen worth $1.26M as of Q2 2026.
  • Ocugen was a new Nuveen position in Q2 2026.
  • Ocugen made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2824 holding.
  • Nuveen first reported a position in Ocugen in Q2 2021 and has held it in 13 quarters since.
  • Nuveen's Ocugen position peaked at $6.09M in Q2 2021.
  • 147 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.